It’s been long-established that quitting smoking prolongs life and that quitting young (below about 40) eliminates all or almost all the mortality costs of smoking. The new paper Smoking Cessation and Short- and Longer-Term Mortality by Eo Rin Cho and colleagues extends this case to more recent data and from several countries. While they confirmContinue reading “Smoking cessation quickly reduces mortality, within 3 years”
Category Archives: lung disease
FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes
As of February 22, 2024, the FDA was continuing to embrace the idea that there is a “continuum of risk” with combusted tobacco as the riskiest and e-cigarettes being substantially less risky. As a result, FDA promotes e-cigarettes as a way for smokers to reduce risk. This view is based on the fact that e-cigarettesContinue reading “FDA needs to reconsider its promotion of the “continuum of risk” for e-cigarettes”
E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone
It is an article of faith among e-cigarette advocates that they are substantially less risky than cigarettes. Rather than being based on the actual associations between e-cigarette use and disease, this belief is based on the fact that e-cigarettes do not burn tobacco, so avoid the toxic combustion products that cigarettes produce. In recent years,Continue reading “E-cigs have similar risks to cigs for some diseases and nearly as high for others. Dual use riskier than smoking alone”
COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote
In the lead up to the WHO Framework Convention on Tobacco Control Tenth Conference of the Parties that starts today, advocates for e-cigarettes and other “reduced harm” tobacco products have been busy again arguing that delegates should embrace these products. In reviewing some of this material, I have been struck by the fact that theirContinue reading “COP10 delegates need to base decisions on latest e-cig evidence, not the same old studies e-cig advocates promote”
Replacing 50% of cigs with ecigs or HTP had no lung benefit
E-cigarette advocates and tobacco harm reduction advocates, as well as the FDA, have long promoted a 50% reduction in cigarette smoking as a positive outcome when assessing the value of e-cigarettes (recent example). The FDA’s use of this benchmark is particularly surprising because in 2021 FDA scientists published a meta-analysis of the effects of smokers reducingContinue reading “Replacing 50% of cigs with ecigs or HTP had no lung benefit”
More evidence that ecigs cause lung disease in youth like cigs; dual use is worse
Richa Mukerjee and colleagues’ new paper, “ENDS, cigarettes, and respiratory illness: Longitudinal associations among US youth,” adds strong evidence to the conclusion that e-cigarettes cause lung disease (bronchitis, pneumonia, or chronic cough) among young people (age 12-17). They used 6 years of longitudinal data (where you follow the same people forward in time) to measureContinue reading “More evidence that ecigs cause lung disease in youth like cigs; dual use is worse”
New strong evidence that Juul is more toxic to lungs and hearts than earlier e-cigs
Two new papers strongly suggest that Juul (and, likely, other fourth generation e-cigarettes) are more dangerous than earlier tank systems. One, Differential Toxicity of Electronic Cigarette Aerosols Generated from Different Generations of Devices In Vitro and In Vivo, finds that Juul has higher pulmonary toxicity than earlier tank systems and the second, Nicotine Formulation InfluencesContinue reading “New strong evidence that Juul is more toxic to lungs and hearts than earlier e-cigs”
First longitudinal evidence linking e-cig use and death
Shauna Goldberg Scott and her colleagues recently published the first longitudinal evidence (where people are followed forward in time, the strongest kind of epidemiological study) showing that e-cigarette use was associated with increased risk of death. Their paper, Demographic, Clinical, and Behavioral Factors Associated With Electronic Nicotine Delivery Systems Use in a Large Cohort inContinue reading “First longitudinal evidence linking e-cig use and death”
Improving EPA’s cumulative risk assessment procedures
In response to President Biden’s 2021 Executive Orders to advance racial equity, increase resources for underserved communities, and address the climate crisis, the Environmental Protection Agency has developed and released “Draft Proposed Principles of Cumulative Risk Assessment under the Toxic Substances Control Act.” While the draft includes many good points, in some ways it willContinue reading “Improving EPA’s cumulative risk assessment procedures”
UC publishes oral history of Stanton Glantz: Putting Cardiovascular, Epidemiological, Economic, Political, and Policy Research into Action at UC San Francisco and Beyond
Today the Oral History Center at the University of California Bancroft Library published an oral history of my career, which is freely available to all. Beginning in elementary school in Cleveland, Ohio, the history follows me through college and gradual school. It discusses my work to develop the emergency protocols for the Apollo 5 missionContinue reading “UC publishes oral history of Stanton Glantz: Putting Cardiovascular, Epidemiological, Economic, Political, and Policy Research into Action at UC San Francisco and Beyond”
Stanton Glantz blog 